Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$374K Sell
15,526
-104
-0.7% -$2.72K 0.21% 84
2026
Q1
$446K Sell
15,630
-551
-3% -$14.7K 0.29% 62
2025
Q4
$403K Buy
16,181
+914
+6% +$23K 0.24% 78
2025
Q3
$389K Buy
15,267
+562
+4% +$13.9K 0.25% 78
2025
Q2
$356K Sell
14,705
-111
-0.7% -$2.59K 0.26% 76
2025
Q1
$375K Sell
14,816
-186
-1% -$4.87K 0.38% 65
2024
Q4
$398K Buy
15,002
+120
+0.8% +$3.25K 0.38% 59
2024
Q3
$431K Buy
14,882
+126
+0.9% +$3.68K 0.44% 57
2024
Q2
$413K Buy
14,756
+224
+2% +$6.17K 0.45% 53
2024
Q1
$403K Sell
14,532
-400
-3% -$11.1K 0.48% 54
2023
Q4
$430K Buy
+14,932
New +$451K 0.56% 44

Other funds holding PFE

OneFund LLC's PFE Position: Q2 2026 in Review

OneFund LLC reduced its Pfizer (PFE) stake by 0.67% in Q2 2026, selling an estimated $2.72K and leaving 15,526 shares worth $374K. The position accounts for 0.21% of the portfolio, ranked #84.

OneFund LLC first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $446K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • OneFund LLC held 15,526 shares of Pfizer worth $374K as of Q2 2026.
  • OneFund LLC sold 104 Pfizer shares in Q2 2026, an estimated $2.72K.
  • Pfizer made up 0.21% of OneFund LLC's portfolio in Q2 2026, its #84 holding.
  • OneFund LLC first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • OneFund LLC's Pfizer position peaked at $446K in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on OneFund LLC's 13F filing for Q2 2026, filed 24 Aug 2026.